Who owns NEUROBO PHARMACEUTICALS INC?
- CUSIP Number: 64132r206
Tip: Access positions for across all investors
Analyze quarterly positions in Neurobo Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Neurobo Pharmaceuticals stock
Who bought or sold NEUROBO PHARMACEUTICALS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Geode Capital Management | 139k | $66k | 100% | Sep 2023 |
|
BlackRock | 42k | $20k | 0% | Sep 2023 |
|
State Street Corporation | 23k | $11k | 100% | Sep 2023 |
|
Tower Research Capital | 12k | $5.9k | 12% | Sep 2023 |
|
Brian McDonald | 22.00 | $9.999000 | 100% | Sep 2023 |
|
Morgan Stanley | 2.00 | $1.000000 | 0% | Sep 2023 |
|
Who sold out of Neurobo Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Vanguard Group | Sep 2023 | 70k | $33k |
Citadel Advisors | Sep 2023 | 46k | $22k |
Two Sigma Securities | Sep 2023 | 43k | $21k |
Virtu Financial | Sep 2023 | 32k | $15k |
Wells Fargo & Company | Sep 2023 | 188.00 | $88.999200 |
UBS Group | Sep 2023 | 142.00 | $68.003800 |
Bank of America Corporation | Sep 2023 | 8.00 | $4.000000 |